Opus Genetics, Inc. (IRD)
4.76
-0.11
(-2.26%)
USD |
NASDAQ |
Sep 25, 16:00
4.765
0.00 (0.00%)
After-Hours: 19:59
Opus Genetics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2026 | 19.81 |
| March 27, 2026 | 19.81 |
| March 26, 2026 | 20.58 |
| March 25, 2026 | 21.63 |
| March 24, 2026 | 20.54 |
| March 23, 2026 | 20.90 |
| March 20, 2026 | 19.99 |
| March 19, 2026 | 20.86 |
| March 18, 2026 | 21.22 |
| March 17, 2026 | 21.86 |
| March 16, 2026 | 23.64 |
| March 13, 2026 | 22.91 |
| March 12, 2026 | 22.04 |
| March 11, 2026 | 22.82 |
| March 10, 2026 | 22.09 |
| March 09, 2026 | 21.72 |
| March 06, 2026 | 22.27 |
| March 05, 2026 | 21.72 |
| March 04, 2026 | 20.81 |
| March 03, 2026 | 19.35 |
| March 02, 2026 | 19.72 |
| February 27, 2026 | 18.94 |
| February 26, 2026 | 16.35 |
| February 25, 2026 | 15.94 |
| February 24, 2026 | 16.58 |
| Date | Value |
|---|---|
| February 23, 2026 | 15.71 |
| February 20, 2026 | 15.44 |
| February 19, 2026 | 16.26 |
| February 18, 2026 | 17.08 |
| February 17, 2026 | 17.71 |
| February 13, 2026 | 16.58 |
| February 12, 2026 | 15.44 |
| February 11, 2026 | 14.98 |
| February 10, 2026 | 15.89 |
| February 09, 2026 | 15.39 |
| February 06, 2026 | 13.71 |
| February 05, 2026 | 11.75 |
| February 04, 2026 | 10.43 |
| February 03, 2026 | 10.93 |
| February 02, 2026 | 10.57 |
| January 30, 2026 | 10.52 |
| January 29, 2026 | 11.38 |
| January 28, 2026 | 12.30 |
| January 27, 2026 | 12.89 |
| January 26, 2026 | 12.80 |
| January 23, 2026 | 11.66 |
| January 22, 2026 | 11.38 |
| January 21, 2026 | 10.75 |
| January 20, 2026 | 10.29 |
| January 16, 2026 | 9.563 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Faeth Therapeutics, Inc. | 4.182 |
| Perspective Therapeutics, Inc. | 0.8877 |
| Rezolute, Inc. | 3.734 |
| Praxis Precision Medicines, Inc. | 5.845 |
| Nuvectis Pharma, Inc. | 59.43 |
Price to Book Value Related Metrics
| PS Ratio | 40.91 |
| Price | 4.76 |
| Earnings Yield | -28.92% |
| Market Cap | 393.40M |